UBS Group’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.7K | Buy |
10,658
+10,580
| +13,564% | +$18.6K | ﹤0.01% | 7181 |
|
|
2025
Q1 | $106 | Sell |
78
-1,005
| -93% | -$1.37K | ﹤0.01% | 8621 |
|
|
2024
Q4 | $4.11K | Buy |
+1,083
| New | +$4.11K | ﹤0.01% | 7545 |
|
|
2024
Q1 | – | Sell |
-50
| Closed | -$344 | – | 8566 |
|
|
2023
Q4 | $344 | Buy |
+50
| New | +$344 | ﹤0.01% | 7498 |
|
|
2023
Q2 | – | Sell |
-668
| Closed | -$2.94K | – | 8318 |
|
|
2023
Q1 | $2.94K | Sell |
668
-25
| -4% | -$110 | ﹤0.01% | 7314 |
|
|
2022
Q4 | $4.09K | Buy |
693
+543
| +362% | +$3.2K | ﹤0.01% | 8190 |
|
|
2022
Q3 | $1K | Buy |
150
+50
| +50% | +$333 | ﹤0.01% | 8912 |
|
|
2022
Q2 | $1K | Sell |
100
-41
| -29% | -$410 | ﹤0.01% | 8904 |
|
|
2022
Q1 | $6K | Sell |
141
-454
| -76% | -$19.3K | ﹤0.01% | 7930 |
|
|
2021
Q4 | $47K | Buy |
+595
| New | +$47K | ﹤0.01% | 5867 |
|
|
2021
Q3 | – | Sell |
-148
| Closed | -$15K | – | 8712 |
|
|
2021
Q2 | $15K | Buy |
148
+61
| +70% | +$6.18K | ﹤0.01% | 6549 |
|
|
2021
Q1 | $9K | Buy |
+87
| New | +$9K | ﹤0.01% | 6988 |
|